Payment overview · 2025
General Payments
$205.96
2 reported records · 2 companies
Healthcare provider profile · identity verified
Robert Thomas, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LORAIN, OH · NPI 1841353083
Verified facts
What the public records show
CMS Open Payments records show Robert Thomas, MD received $205.96 in general payments during 2025 across 2 reported records.
Janssen Pharmaceuticals, Inc accounted for 60.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Vraylar by this doctor in 2024.
Janssen Pharmaceuticals, Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XARELTO as an associated drug or biological on 28 records involving 28 distinct recipient NPIs. Public Medicare Part D data also shows 69 claims for Xarelto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc | Unresolved — no canonical attribution shown | $124.90 | 60.6% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $81.06 | 39.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $205.96 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SPRAVATO Normalized: spravato |
Drug | Janssen Pharmaceuticals, Inc | $124.90 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $81.06 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $81.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| Janssen Pharmaceuticals, Inc Exact reporting entity; no affiliate inference |
2025 | XARELTO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 28 recipient NPIs · example record 1174296970 |
Xarelto · 2024 Exact normalized brand match · 1 Part D row |
69 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 730 | 172 |
| Amlodipine Besylate | Amlodipine Besylate | 555 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 487 | 115 |
| Omeprazole | Omeprazole | 323 | 77 |
| Gabapentin | Gabapentin | 305 | 74 |
| Losartan Potassium | Losartan Potassium | 298 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 296 | 84 |
| Furosemide | Furosemide | 293 | 79 |
| Tamsulosin Hcl | Tamsulosin Hcl | 292 | 76 |
| Lisinopril | Lisinopril | 282 | 76 |
| Metformin Hcl | Metformin Hcl | 271 | 48 |
| Metformin Hcl Er | Metformin Hcl | 253 | 67 |
| Hydrochlorothiazide | Hydrochlorothiazide | 252 | 72 |
| Metoprolol Succinate | Metoprolol Succinate | 240 | 68 |
| Allopurinol | Allopurinol | 224 | 51 |
| Citalopram Hbr | Citalopram Hydrobromide | 224 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 220 | 49 |
| Simvastatin | Simvastatin | 198 | 53 |
| Trulicity | Dulaglutide | 184 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 176 | 59 |
| Ozempic | Semaglutide | 169 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 157 | 42 |
| Sertraline Hcl | Sertraline Hcl | 149 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 147 | 64 |
| Trazodone Hcl | Trazodone Hcl | 143 | 29 |
| Potassium Chloride | Potassium Chloride | 139 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 138 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 135 | 30 |
| Glipizide | Glipizide | 130 | 26 |
| Donepezil Hcl | Donepezil Hcl | 125 | 27 |
| Meloxicam | Meloxicam | 122 | 40 |
| Carvedilol | Carvedilol | 119 | 27 |
| Finasteride | Finasteride | 118 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 118 | 13 |
| Buspirone Hcl | Buspirone Hcl | 117 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 114 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 113 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 26 |
| Famotidine | Famotidine | 109 | 24 |
| Tramadol Hcl | Tramadol Hcl | 107 | 31 |
| Jardiance | Empagliflozin | 102 | 25 |
| Montelukast Sodium | Montelukast Sodium | 102 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 33 |
| Ibuprofen | Ibuprofen | 93 | 35 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 90 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 84 | 19 |
| Eliquis | Apixaban | 80 | 21 |
| Risperidone | Risperidone | 80 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 79 | 17 |
| Prednisone | Prednisone | 79 | 32 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 78 | 21 |
| Bupropion Xl | Bupropion Hcl | 78 | 20 |
| Memantine Hcl | Memantine Hcl | 78 | 15 |
| Divalproex Sodium | Divalproex Sodium | 76 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 71 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 69 | 16 |
| Xarelto | Rivaroxaban | 69 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 68 | 14 |
| Atenolol | Atenolol | 67 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 66 | 25 |
| Chlorthalidone | Chlorthalidone | 65 | 16 |
| Glimepiride | Glimepiride | 65 | 17 |
| Pregabalin | Pregabalin | 65 | 15 |
| Topiramate | Topiramate | 64 | 14 |
| Mirtazapine | Mirtazapine | 63 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 11 |
| Levetiracetam | Levetiracetam | 62 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 61 | 15 |
| Azithromycin | Azithromycin | 61 | 47 |
| Ondansetron Odt | Ondansetron | 57 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 57 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 57 | 14 |
| Spironolactone | Spironolactone | 57 | 16 |
| Aripiprazole | Aripiprazole | 56 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 12 |
| Lorazepam | Lorazepam | 52 | 23 |
| Baclofen | Baclofen | 50 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | 12 |
| Meclizine Hcl | Meclizine Hcl | 49 | 19 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 45 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 45 | suppressed |
| Nystatin | Nystatin | 45 | 22 |
| Ezetimibe | Ezetimibe | 44 | 14 |
| Midodrine Hcl | Midodrine Hcl | 43 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | 14 |
| Perphenazine | Perphenazine | 42 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 41 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Januvia | Sitagliptin Phosphate | 35 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 32 | suppressed |
| Mounjaro | Tirzepatide | 32 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 23 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Alprazolam | Alprazolam | 30 | 11 |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 29 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 26 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 26 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 23 |
| Celecoxib | Celecoxib | 25 | suppressed |
| Irbesartan | Irbesartan | 25 | suppressed |
| Cephalexin | Cephalexin | 24 | 13 |
| Lovastatin | Lovastatin | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 22 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | 11 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 21 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 15 |
| Etodolac | Etodolac | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Meropenem | Meropenem | 20 | suppressed |
| Vraylar | Cariprazine Hcl | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 17 |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Fluconazole | Fluconazole | 18 | 14 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Cimetidine | Cimetidine | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Jantoven | Warfarin Sodium | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Chlorzoxazone | Chlorzoxazone | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 14 |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 15 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Probenecid | Probenecid | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Alprazolam Er | Alprazolam | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Praluent Pen | Alirocumab | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Klayesta | Nystatin | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $205.96 · 2 records | Janssen Pharmaceuticals, Inc | QULIPTA, SPRAVATO, UBRELVY | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error